Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for ResMed Inc. (RMD : NYSE)

• Company Description    ResMed Inc. is a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions. Number of Employees: 7,970

• Price / Volume Information    Yesterday's Closing Price: $196.86 Daily Weekly Monthly 20 Day Moving Average: 632,251 shares Shares Outstanding: 146.29 (millions) Market Capitalization: $28,797.60 (millions) Beta: 0.45 52 Week High: $301.34 52 Week Low: $189.40 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -15.95% -8.25% 12 Week -15.05% -8.19% Year To Date -24.42% -10.48%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 9001 SPECTRUM CENTER BLVD. - SAN DIEGO,CA 92123 USA ph: 858-836-5000 fax: 858-836-5501 investorrelations@resmed.com http://www.resmed.com

• General Corporate Information    Officers MichaelJ.Farrell - Chief executive officer and director BrettA.Sandercock - Chief financial officer PeterC.Farrell - Non-executive chairman CarolJ.Burt - Director Harjit Gill - Director Peer Information ResMed Inc. (BJCT) ResMed Inc. (CADMQ) ResMed Inc. (APNO) ResMed Inc. (UPDC) ResMed Inc. (IMTIQ) ResMed Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 761152107 SIC: 3841 Fiscal Year Fiscal Year End: June Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/04/22 Share - Related Items Shares Outstanding: 146.29 Most Recent Split Date: 8.00 (2.00:1) Beta: 0.45 Market Capitalization: $28,797.60 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.85% Current Fiscal Quarter EPS Consensus Estimate: $1.49 Indicated Annual Dividend: $1.68 Current Fiscal Year EPS Consensus Estimate: $5.73 Payout Ratio: 0.30 Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio: -0.07 Estmated Long-Term EPS Growth Rate: 15.73% Last Dividend Paid: 05/11/2022 - $0.42 Next EPS Report Date: 08/04/22

• Fundamental Ratios P/E Current FY Estimate: 34.33 Trailing 12 Months: 34.84 PEG Ratio: 2.18 Price Ratios Price/Book: 8.78 Price/Cash Flow: 29.47 Price / Sales: 8.14 EPS Growth vs. Year Ago Period: 1.54% vs. Previous Quarter: -10.20% Sales Growth vs. Year Ago Period: 12.45% vs. Previous Quarter: -3.40% ROE 03/31/22 - 26.91 12/31/21 - 28.12 09/30/21 - 28.46 ROA 03/31/22 - 17.39 12/31/21 - 17.62 09/30/21 - 17.56 Current Ratio 03/31/22 - 2.55 12/31/21 - 2.49 09/30/21 - 2.54 Quick Ratio 03/31/22 - 1.56 12/31/21 - 1.54 09/30/21 - 1.73 Operating Margin 03/31/22 - 23.45 12/31/21 - 24.02 09/30/21 - 24.40 Net Margin 03/31/22 - 22.02 12/31/21 - 15.16 09/30/21 - 14.92 Pre-Tax Margin 03/31/22 - 27.17 12/31/21 - 27.68 09/30/21 - 27.67 Book Value 03/31/22 - 22.41 12/31/21 - 21.51 09/30/21 - 20.77 Inventory Turnover 03/31/22 - 2.79 12/31/21 - 2.93 09/30/21 - 3.00 Debt-to-Equity 03/31/22 - 0.20 12/31/21 - 0.21 09/30/21 - 0.26 Debt-to-Capital 03/31/22 - 16.94 12/31/21 - 17.51 09/30/21 - 20.78

Powered by Zacks Investment Research ©